Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vincent

Showing results (391-400 of 428) with videos related to

Pageof 43
Sort By:
Biorxiv : the Preprint Server for Biology|March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT CarcinomaJeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
Frontiers in Oncology|February 8, 2021
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain MetastasesDimitri G Trembath, Eric S Davis, Shanti Rao, et al.
Immunity|January 16, 2020
The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and FunctionalityChaofan Li, Bibo Zhu, Young Min Son, et al.
JCI Insight|November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinomaChristopher G Wood, James E Ferguson, Joel S Parker, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 19, 2023
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast TumorsBenjamin G Vincent, Danielle M File, Karen P McKinnon, et al.
JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Nature Communications|May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancerWolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
The Journal of Clinical Investigation|April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host diseaseDanny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Pageof 43

Showing results (391-400 of 428) with videos related to

Sort By:
Pageof 43
Biorxiv : the Preprint Server for Biology|March 31, 2025
PRAME Epitopes are T-Cell Immunovulnerabilities in <i>BRD4::NUTM1</i> Initiated NUT CarcinomaJeffrey L Jensen, Sara K Peterson, Shawn Yu, et al.
Frontiers in Oncology|February 8, 2021
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain MetastasesDimitri G Trembath, Eric S Davis, Shanti Rao, et al.
Immunity|January 16, 2020
The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8<sup>+</sup> T Cell Fitness and FunctionalityChaofan Li, Bibo Zhu, Young Min Son, et al.
JCI Insight|November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinomaChristopher G Wood, James E Ferguson, Joel S Parker, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 19, 2023
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast TumorsBenjamin G Vincent, Danielle M File, Karen P McKinnon, et al.
JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Nature Communications|May 24, 2024
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancerWolfgang Beckabir, Mi Zhou, Jin Seok Lee, et al.
The Journal of Clinical Investigation|April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host diseaseDanny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Pageof 43